Urologists see healthy increase in compensation

Article

Urologists' median compensation went up 6.84% from 2002 to 2003, marking the largest percentage increase among eight surgical specialties, according to findings from the American Medical Group Association's 2004 Medical Group Compensation & Financial Survey.

Urologists' median compensation went up 6.84% from 2002 to 2003, marking the largest percentage increase among eight surgical specialties, according to findings from the American Medical Group Association's 2004 Medical Group Compensation & Financial Survey. Median compensation for urologists was $319,125, compared with $298,703 in 2002.

Median gross charges for urology were slightly over $1.4 million in 2003 versus slightly over $1.2 million in 2002-an increase of 17.48%, by far the largest increase among the surgical specialties. Emergency care was a distant second at 6.99%.

On the down side, urologists' median relative work value units decreased 5.98% in 2003, the largest drop among the surgical subspecialties. Median work RVUs were $6,722 in 2002, and $6,320 in 2003.

The AMGA survey includes salary and productivity data on physicians in 98 specialties, including eight surgical specialties: cardiac/thoracic surgery, emergency care, general surgery, gynecology and obstetrics, ophthalmology, orthopedic surgery, otolaryngology, and urology. Data were derived from 30,500 medical group physicians throughout the United States.

Related Videos
Kevin M. Wymer, MD
Video 7 - "Multidisciplinary Collaboration and Expert Insights in the Management of Advanced Prostate Cancer"
Video 6 - "Emerging AR Targeting Agents and CDK4/6 Inhibitors in Metastatic Prostate Cancer and Potential Impact on the Treatment Landscape"
Video 5 - "Targeting the Androgen Receptor Pathway and Overcoming Treatment Resistance in Advanced Prostate Cancer"
Video 4 - "Androgen Receptor Signaling and Its Role in Driving Prostate Cancer Metastasis"
Video 3 - "Treatment Selection in Metastatic and Castration Resistant Prostate Cancer: Optimizing Outcomes and Preserving Patient Quality of Life"
Video 2 - "Predicting Risk and Guiding Care: Biomarkers & Genetic Testing in Prostate Cancer"
Video 1 - "Metastatic Prostate Cancer: Background and Patient Prognosis"
Related Content
© 2024 MJH Life Sciences

All rights reserved.